Liu Yanhong, Chen Linjiao, Shi Qingyang, Zhao Qing, Ma Hongshuang
Center for Reproductive Medicine, Center for Prenatal Diagnosis, First Hospital, Jilin University, Changchun, China.
Department of Obstetrics, First Hospital, Jilin University, Changchun, China.
Front Pharmacol. 2021 Oct 27;12:748102. doi: 10.3389/fphar.2021.748102. eCollection 2021.
Tumor microenvironment-responsive polypeptide nanogels belong to a biomaterial with excellent biocompatibility, easily adjustable performance, biodegradability, and non-toxic properties. They are developed for selective delivery of antitumor drugs into target organs to promote tumor cell uptake, which has become an effective measure of tumor treatment. Endogenous (such as reduction, reactive oxygen species, pH, and enzyme) and exogenous (such as light and temperature) responsive nanogels can release drugs in response to tumor tissues or cells to improve drug distribution and reduce drug side effects. This article systematically introduces the research progress in tumor microenvironment-responsive polypeptide nanogels to deliver antitumor drugs and provides a reference for the development of antitumor nanoformulations.
肿瘤微环境响应性多肽纳米凝胶属于一类具有优异生物相容性、性能易于调节、可生物降解且无毒的生物材料。它们被开发用于将抗肿瘤药物选择性地递送至靶器官,以促进肿瘤细胞摄取,这已成为肿瘤治疗的一种有效手段。内源性(如还原、活性氧、pH值和酶)和外源性(如光和温度)响应性纳米凝胶可响应肿瘤组织或细胞释放药物,以改善药物分布并降低药物副作用。本文系统介绍了肿瘤微环境响应性多肽纳米凝胶用于递送抗肿瘤药物的研究进展,为抗肿瘤纳米制剂的开发提供参考。